Efficacy of crizotinib inhibiting specific molecular pathways in non-small-cell lung carcinoma

Expert Review of Anticancer Therapy
Hamid R Mirshahidi, Saied Mirshahidi

Abstract

The US FDA granted approval for crizotinib as the first-line treatment for patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase rearranged metastatic non-small-cell lung cancer, on November 20, 2013. Crizotinib is a customized and improved therapeutic option for patients with non-small-cell lung cancer that enhances overall survival without increasing toxicity. In the future, new targeted therapies may achieve additional indications for treating patients with lung cancer. This article summarizes data from crizotinib studies.

References

Dec 15, 2000·Oncogene·D R RobinsonS F Lin
Feb 7, 2002·The European Respiratory Journal·E BrambillaY Shimosato
Oct 6, 2005·Journal of the National Cancer Institute·Brenda K EdwardsLinda W Pickle
Jul 4, 2006·Journal of the National Comprehensive Cancer Network : JNCCN·David S EttingerUNKNOWN National Comprehensive Cancer Network (NCCN)
May 15, 2007·Oncogene·M M McKay, D K Morrison
May 24, 2007·Blood·Hesham M Amin, Raymond Lai
Aug 19, 2007·Medicinal Research Reviews·Rongshi Li, Stephan W Morris
Dec 15, 2007·Genes & Development·Sreenath V Sharma, Jeffrey Settleman
Dec 22, 2007·Nature Reviews. Cancer·Roberto ChiarleGiorgio Inghirami
Jan 2, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kentaro InamuraYuichi Ishikawa
Feb 5, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kazuya ShinmuraHaruhiko Sugimura
Mar 6, 2008·Neoplasia : an International Journal for Oncology Research·Sven PernerMark A Rubin
Apr 17, 2008·British Journal of Cancer·Y FukuyoshiM Mori
Sep 10, 2008·Biochimica Et Biophysica Acta·Jaime AcquavivaAl Charest
Oct 17, 2008·Nature·Yuyan ChenSeishi Ogawa
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kengo TakeuchiHiroyuki Mano
Jan 27, 2009·Cancer·Daisy Wing-Sze WongUNKNOWN University of Hong Kong Lung Cancer Study Group
Apr 23, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kengo TakeuchiHiroyuki Mano
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alice T ShawA John Iafrate
Jan 27, 2010·Expert Opinion on Therapeutic Patents·John Porter
Oct 29, 2010·The New England Journal of Medicine·Eunice L KwakA John Iafrate
May 31, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuA John Iafrate
Jul 1, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Junko TanizakiKazuhiko Nakagawa
Jan 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristin BergethonA John Iafrate
Mar 1, 2012·British Journal of Cancer·A J Atherly, D R Camidge
Feb 15, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lynette M ShollJason L Hornick
May 31, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kurtis D Davies, Robert C Doebele
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Jul 3, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Hiroaki NittaThomas M Grogan
Nov 7, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Richard SchwabLaszlo Urban
Feb 5, 2014·Journal of the National Cancer Institute·Carlo Gambacorti PasseriniRocco Piazza
Feb 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandjar DjalalovNatasha B Leighl
Mar 29, 2014·Cancer Discovery·Luc FribouletJeffrey A Engelman
Aug 15, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ReckUNKNOWN ESMO Guidelines Working Group

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.